Clinical Trial Update: Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of Pazopanib plus Vinorelbine in metastatic non-small cell lung cancer and metastatic breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Pazopanib (Pazopanib)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Northwestern University | Conditions: Metastatic Non Small Cell Lung Cancer, Metastatic Breast Cancer | Phase 1 | Status: TERMINATED